Identifying clinical and psychological correlates of persistent negative symptoms in early-onset psychotic disorders

Abstract

Persistent negative symptoms (PNS) contribute to impairment in psychosis. The characteristics of PNS seen in youth remained under-investigated. We aimed to demonstrate clinical, treatment-related, and psychosocial characteristics of PNS in early-onset schizophrenia-spectrum disorders (EOSD). 132 patients with EOSD were assessed with Positive and Negative Symptom Scale, Brief Negative Symptom Scale, Calgary Depression Scale for Schizophrenia, and Simpson-Angus Scale. Parenting skills and resilience were evaluated using Parental Attitude Research Instrument and Child and Youth Resilience Measure-12. Longer duration of untreated psychosis (DUP) and prodromal phase were found in primary and secondary PNS groups, compared to the non-PNS group. The primary PNS group was characterized by earlier age-onset, lower smoking rates, and more common clozapine use. Resilience and egalitarian/democratic parenting were negatively correlated with symptoms related to motivation/pleasure and blunted expression. More blunted expression-related symptoms and longer DUP in the first episode significantly predicted primary/secondary PNS at follow-up. Using the data from total negative symptom scores and DUP, Receiver Operating Characteristic analyses significantly differentiated primary/secondary PNS groups from the non-PNS counterparts. PNS associated with blunted expression and low motivation/pleasure in the first episode could persist into clinical follow-up. Effective pharmacological treatment and psychosocial interventions are needed in youth.

Keywords

Persistent negative symptoms youth adolescent early-onset schizophrenia

Get full access to this article

View all access options for this article.

References

Addington

Maticka-Tyndale

Joyce

(1992). Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research, 6(3), 201–208. https://doi.org/10.1016/0920-9964(92)90003-n

Alphs

Panagides

Lancaster

(2007). Asenapine in the treatment of negative symptoms of schizophrenia: Clinical trial design and rationale. Psychopharmacology Bulletin, 40(2), 41-53. https://pubmed.ncbi.nlm.nih.gov/17514185/.

Amaresha

A. C.

Venkatasubramanian

(2012). Expressed emotion in schizophrenia: An overview. Indian Journal of Psychological Medicine, 34(1), 12–20. https://doi.org/10.4103/0253-7176.96149

American Psychiatric Association . (2013). Diagnostic and statistical manual of mental disorders (5th ed.).

Blanchard

J. J.

Cohen

A. S.

(2006). The structure of negative symptoms within schizophrenia: Implications for assessment. Schizophrenia Bulletin, 32(2), 238–245. https://doi.org/10.1093/schbul/sbj013

Boonstra

Klaassen

Sytema

Marshall

De Haan

Wunderink

Wiersma

(2012). Duration of untreated psychosis and negative symptoms–a systematic review and meta-analysis of individual patient data. Schizophrenia Research, 142(1–3), 12–19. https://doi.org/10.1016/j.schres.2012.08.017

Bora

Yalincetin

Akdede

B. B.

Alptekin

(2018). Duration of untreated psychosis and neurocognition in first-episode psychosis: A meta-analysis. Schizophrenia Research, 193, 3-10. https://doi.org/10.1016/j.schres.2017.06.021.

Bucci

Mucci

van Rossum

I. W.

Aiello

Arango

Baandrup

Buchanan

R. W.

Dazzan

Demjaha

Díaz-Caneja

C. M.

Giordano

G. M.

Glenthøj

B. Y.

Leucht

McGuire

Rodriguez-Jimenez

Vignapiano

Kahn

R. S.

Galderisi

(2020). Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning. European Neuropsychopharmacology, 34, 76-86. https://doi.org/10.1016/j.euroneuro.2020.03.010.

Buchanan

R. W.

(2007). Persistent negative symptoms in schizophrenia: An overview. Schizophrenia Bulletin, 33(4), 1013–1022. https://doi.org/10.1093/schbul/sbl057

10.

Butler

Berry

Varese

Bucci

(2018). Are family warmth and positive remarks related to outcomes in psychosis? A systematic review. Psychological Medicine, 48(8), 1250–1265. https://doi.org/10.1017/S0033291718003768

11.

Butzlaff

R. L.

Hooley

J. M.

(1998). Expressed emotion and psychiatric relapse: A meta-analysis. Archives of General Psychiatry, 55(6), 547–552. https://doi.org/10.1001/archpsyc.55.6.547

12.

Chang

W. C.

Hui

C. L.

Tang

J. Y.

Wong

G. H.

Lam

M. M.

Chan

S. K.

Chen

E. Y.

(2011). Persistent negative symptoms in first-episode schizophrenia: A prospective three-year follow-up study. Schizophrenia Research, 133(1–3), 22–28. https://doi.org/10.1016/j.schres.2011.09.006

13.

Chen

Mao

Sun

Zhou

(2019). Positive Coping and resilience as mediators between negative symptoms and disability among patients with schizophrenia. Frontiers of Psychiatry, 10, 641. https://doi.org/10.3389/fpsyt.2019.00641

14.

Correll

C. U.

Schooler

N. R.

(2020). Negative symptoms in schizophrenia: A review and clinical guide for recognition, assessment, and treatment. Neuropsychiatric Disease and Treatment, 16, 519–534. https://doi.org/10.2147/NDT.S225643

15.

Downs

Dean

Lechler

Sears

Patel

Shetty

Hotopf

Ford

Kyriakopoulos

Diaz-Caneja

C. M.

Arango

MacCabe

J. H.

Hayes

R. D.

Pina-Camacho

(2019). Negative symptoms in early-onset psychosis and their association with antipsychotic treatment failure. Schizophrenia Bulletin, 45(1), 69–79. https://doi.org/10.1093/schbul/sbx197

16.

Elis

Caponigro

J. M.

Kring

A. M.

(2013). Psychosocial treatments for negative symptoms in schizophrenia: Current practices and future directions. Clinical Psychology Review, 33(8), 914–928. https://doi.org/10.1016/j.cpr.2013.07.001

17.

Ergul

Ucok

(2015). Negative symptom subgroups have different effects on the clinical course of schizophrenia after the first episode: A 24-month follow up study. European Psychiatry, 30(1), 14–19. https://doi.org/10.1016/j.eurpsy.2014.07.005

18.

Galderisi

Mucci

Bitter

Libiger

Bucci

Fleischhacker

W. W.

Kahn

R. S.

(2013). Persistent negative symptoms in first episode patients with schizophrenia: Results from the European first episode schizophrenia trial. European Neuropsychopharmacology, 23(3), 196–204. https://doi.org/10.1016/j.euroneuro.2012.04.019

19.

George

Mallery

(2019). IBM SPSS statistics 26 step by step: A simple guide and reference (16th ed.). Routledge.

20.

Goetz

R. R.

Corcoran

Yale

Stanford

A. D.

Kimhy

Amador

Malaspina

(2007). Validity of a ‘proxy’ for the deficit syndrome derived from the positive and negative syndrome scale (PANSS). Schizophrenia Research, 93(1–3), 169–177. https://doi.org/10.1016/j.schres.2007.02.018

21.

Hunter

Barry

(2012). Negative symptoms and psychosocial functioning in schizophrenia: Neglected but important targets for treatment. European Psychiatry, 27(6), 432–436. https://doi.org/10.1016/j.eurpsy.2011.02.015

22.

Izydorczyk

Sitnik-Warchulska

Kühn-Dymecka

Lizińczyk

(2019). Resilience, sense of coherence, and coping with stress as predictors of psychological well-being in the course of schizophrenia. The study design. International Journal of Environmental Research and Public Health, 16(7), 1266. https://doi.org/10.3390/ijerph16071266

23.

Jahn

D. R.

Bennett

M. E.

Park

S. G.

Gur

R. E.

Horan

W. P.

Kring

A. M.

Blanchard

J. J.

(2016). The interactive effects of negative symptoms and social role functioning on suicide ideation in individuals with schizophrenia. Schizophrenia Research, 170(2–3), 271–277. https://doi.org/10.1016/j.schres.2015.12.011

24.

Jang

S. K.

Choi

H. I.

Park

Jaekal

Lee

G. Y.

Cho

Y. I.

Choi

K. H.

(2016). A two-factor model better explains heterogeneity in negative symptoms: Evidence from the positive and negative syndrome scale. Frontiers Psychology, 7, 707. https://doi.org/10.3389/fpsyg.2016.00707

25.

Johnson

Gooding

P. A.

Wood

A. M.

Taylor

P. J.

Pratt

Tarrier

(2010). Resilience to suicidal ideation in psychosis: Positive self-appraisals buffer the impact of hopelessness. Behaviour Research and Therapy, 48(9), 883–889. https://doi.org/10.1016/j.brat.2010.05.013

26.

Kirkpatrick

Buchanan

R. W.

Breier

Carpenter

W. T.

Jr. (1993). Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Research, 47(1), 47–56. https://doi.org/10.1016/0165-1781(93)90054-k

27.

Kirkpatrick

Strauss

G. P.

Nguyen

Fischer

B. A.

Daniel

D. G.

Cienfuegos

Marder

S. R.

(2011). The brief negative symptom scale: Psychometric properties. Schizophrenia Bulletin, 37(2), 300–305. https://doi.org/10.1093/schbul/sbq059

28.

Koutra

Triliva

Roumeliotaki

Basta

Lionis

Vgontzas

A. N.

(2016). Family functioning in first-episode and chronic psychosis: The role of patient’s symptom severity and psychosocial functioning. Community Mental Health Journal, 52(6), 710–723. https://doi.org/10.1007/s10597-015-9916-y

29.

LeCompte

Ozer

S. A.

(1978). Child raising attitudes of mothers at three socioeconomic levels in Ankara: A scale adaptation. Turkish Journal of Psychology, 1(1), 5–8. Article in Turkish.

30.

Liebenberg

Ungar

LeBlanc

J. C.

(2013). The CYRM-12: A brief measure of resilience. Canadian Journal of Public Health, 104(2), e131–e135. https://doi.org/10.1007/bf03405676

31.

Lyne

O'Donoghue

Roche

Renwick

Cannon

Clarke

(2018). Negative symptoms of psychosis: A life course approach and implications for prevention and treatment. Early Intervention in Psychiatry, 12(4), 561–571. https://doi.org/10.1111/eip.12501

32.

Makowski

Bodnar

Malla

A. K.

Joober

Lepage

(2016). Age-related cortical thickness trajectories in first episode psychosis patients presenting with early persistent negative symptoms. NPJ Schizophrenia, 2(1), 16029. https://doi.org/10.1038/npjschz.2016.29

33.

Malla

A. K.

Norman

R. M.

Takhar

Manchanda

Townsend

Scholten

Haricharan

(2004). Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis? The Journal of Nervous and Mental Disease, 192(7), 455–463. https://doi.org/10.1097/01.nmd.0000131804.34977.c1

34.

Rabinowitz

Werbeloff

Caers

Mandel

F. S.

Stauffer

Menard

Kinon

Kapur

(2013). Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences. Schizophrenia Research, 150(2–3), 334–338. https://doi.org/10.1016/j.schres.2013.06.023

35.

Schaefer

E. S.

Bell

R. Q.

(1958). Development of a parental attitude research instrument. Child Development, 29(3), 339–361. https://doi.org/10.1111/j.1467-8624.1958.tb04891.x

36.

Shaffer

Gould

M. S.

Brasic

Ambrosini

Fisher

Bird

Aluwahlia

(1983). A children's global assessment scale (CGAS). Arch Gen Psychiatry, 40(11), 1228–1231. https://doi.org/10.1001/archpsyc.1983.01790100074010

37.

Simpson

G. M.

Angus

J. W.

(1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum, 45(S212), 11–19. https://doi.org/10.1111/j.1600-0447.1970.tb02066.x

38.

Singh

S. P.

Harley

Suhail

(2013). Cultural specificity of emotional overinvolvement: A systematic review. Schizophrenia Bulletin, 39(2), 449–463. https://doi.org/10.1093/schbul/sbr170

39.

Starling

Williams

L. M.

Hainsworth

Harris

A. W.

(2013). The presentation of early-onset psychotic disorders. The Australian and New Zealand Journal of Psychiatry, 47(1), 43–50. https://doi.org/10.1177/0004867412463615

40.

Stauffer

V. L.

Song

Kinon

B. J.

Ascher-Svanum

Chen

Feldman

P. D.

Conley

R. R.

(2012). Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms. Schizophrenia Research, 134(2–3), 195–201. https://doi.org/10.1016/j.schres.2011.09.028

41.

Stentebjerg-Olesen

Pagsberg

A. K.

Fink-Jensen

Correll

C. U.

Jeppesen

(2016). Clinical characteristics and predictors of outcome of schizophrenia-spectrum psychosis in children and adolescents: A systematic review. Journal of Child Adolescent Psychopharmacology, 26(5), 410–427. https://doi.org/10.1089/cap.2015.0097

42.

Strauss

G. P.

Hong

L. E.

Gold

J. M.

Buchanan

R. W.

McMahon

R. P.

Keller

W. R.

Fischer

B. A.

Catalano

L. T.

Culbreth

A. J.

Carpenter

W. T.

Kirkpatrick

(2012). Factor structure of the brief negative symptom scale. Schizophrenia Research, 142(1–3), 96–98. https://doi.org/10.1016/j.schres.2012.09.007

43.

Strauss

G. P.

Horan

W. P.

Kirkpatrick

Fischer

B. A.

Keller

W. R.

Miski

Buchanan

R. W.

Green

M. F.

Carpenter

W. T.

(2013). Deconstructing negative symptoms of schizophrenia: Avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research, 47(6), 783–790. https://doi.org/10.1016/j.jpsychires.2013.01.015

44.

Torgalsbøen

A. K.

Czajkowski

(2018). Resilience trajectories to full recovery in first-episode schizophrenia. European Psychiatry, 52, 54–60. https://doi.org/10.1016/j.eurpsy.2018.04.007

45.

Ünal

Öktem

Çetin Çuhadaroğlu

Çengel Kültür

S. E.

Akdemir

Foto Özdemir

Çak

H. T.

Ünal

Tıraş

Aslan

Kalaycı

B. M.

Aydos

B. S.

Kütük

Taşyürek

Karaokur

Karabucak

Karakök

Karaer

Artık

(2019). Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 november 2016-Turkish adaptation (K-SADS-PL-DSM-5-T). Turk Psikiyatri Dergisi, 30(1), 42–50. https://doi.org/10.5080/u23408

46.

Üçok

Ergül

(2014). Persistent negative symptoms after first episode schizophrenia: A 2-year follow-up study. Schizophrenia Research, 158(1–3), 241–246. https://doi.org/10.1016/j.schres.2014.07.021

47.

Velligan

D. I.

Roberts

Mintz

Maples

Medellin

Brown

(2015). A randomized pilot study of MOtiVation and Enhancement (MOVE) training for negative symptoms in schizophrenia. Schizophrenia Research, 165(2–3), 175–180. https://doi.org/10.1016/j.schres.2015.04.008

48.

Wambua

G. N.

Kilian

Ntlantsana

Chiliza

(2020). The association between resilience and psychosocial functioning in schizophrenia: A systematic review and meta-analysis. Psychiatry Research, 293, 113374. https://doi.org/10.1016/j.psychres.2020.113374

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.37 MB